Literature DB >> 22018037

Diagnosis and management of diffuse lung disease in children.

Timothy J Vece1, Leland L Fan.   

Abstract

Diffuse lung disease [DLD] in children comprises a group of heterogeneous, rare disorders. Despite the rarity of these diseases there has been a considerable increase in our knowledge of DLD in children including their diagnosis and management. Diagnosis of these diseases requires a detailed history and physical examination, diagnostic imaging, pulmonary function testing, selected and directed laboratory testing, bronchoalveolar lavage and in most cases an open lung biopsy. Once a diagnosis is made, treatment is centred on supportive care including nutritional and supplemental oxygen therapy when needed. Medications including corticosteroids and other immunomodulatory medications are often used. Lung transplantation has been used for final treatment in some cases of DLD. Formation of research collaborations will continue to further our understanding of these diseases.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22018037     DOI: 10.1016/j.prrv.2011.04.001

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  11 in total

Review 1.  ATS Core Curriculum 2017: Part II. Pediatric Pulmonary Medicine.

Authors:  Paul E Moore; Jason T Poston; Debra Boyer; Emily Barsky; Jonathan Gaffin; Kathleen B Boyne; Kristie R Ross; Laura Beth Mann Dosier; Timothy J Vece; Alicia M Casey; Sebastian K Welsh; J Wells Logan; Edward G Shepherd; Pelton A Phinzy; Howard B Panitch; Christina M Papantonakis; Eric D Austin; Amir B Orandi; Maleewan Kitcharoensakkul; Mark K Abe; Amjad Horani; Jordan S Rettig; Jessica Pittman
Journal:  Ann Am Thorac Soc       Date:  2017-08

Review 2.  Etiologies of Chronic Cough in Pediatric Cohorts: CHEST Guideline and Expert Panel Report.

Authors:  Anne B Chang; John J Oppenheimer; Miles Weinberger; Cameron C Grant; Bruce K Rubin; Richard S Irwin
Journal:  Chest       Date:  2017-06-21       Impact factor: 9.410

Review 3.  Interstitial lung disease in infants: new classification system, imaging technique, clinical presentation and imaging findings.

Authors:  Edward Y Lee
Journal:  Pediatr Radiol       Date:  2012-11-15

Review 4.  Update on Diffuse Lung Disease in Children.

Authors:  Timothy J Vece; Lisa R Young
Journal:  Chest       Date:  2016-01-12       Impact factor: 9.410

5.  Different course of lung disease in two siblings with novel ABCA3 mutations.

Authors:  Maarja Hallik; Tarmo Annilo; Mari-Liis Ilmoja
Journal:  Eur J Pediatr       Date:  2013-07-12       Impact factor: 3.183

6.  Children with chronic lung diseases have cognitive dysfunction as assessed by event-related potential (auditory P300) and Stanford-Binet IQ (SB-IV) test.

Authors:  Terez Boshra Kamel; Mahmoud Tarek Abd Elmonaem; Lobna Hamed Khalil; Mona Hamdy Goda; Hossam Sanyelbhaa; Mourad Alfy Ramzy
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-13       Impact factor: 2.503

Review 7.  Clinical application of exhaled nitric oxide measurement in pediatric lung diseases.

Authors:  Angelo Manna; Carlo Caffarelli; Margherita Varini; Carlotta Povesi Dascola; Silvia Montella; Marco Maglione; Francesco Sperlì; Francesca Santamaria
Journal:  Ital J Pediatr       Date:  2012-12-31       Impact factor: 2.638

8.  Serial lung magnetic resonance imaging to monitor disease progression in a child with a diffuse alveolar hemorrhage syndrome.

Authors:  Mohammed Kaleel; Craig Schramm; Melanie Pascal; Michael O'Louglin; Melanie Sue Collins
Journal:  J Clin Med Res       Date:  2015-02-09

Review 9.  Interstitial Lung Disease in Childhood: Clinical and Genetic Aspects.

Authors:  Hiroshi Kitazawa; Shigeo Kure
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-10-11

10.  Diffuse alveolar hemorrhage with histopathologic manifestations of pulmonary capillaritis: Three case reports.

Authors:  Jun Xie; Ying-Yue Zhao; Jing Liu; Guang-Min Nong
Journal:  World J Clin Cases       Date:  2020-06-26       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.